IL10 and neoplasm: Alternatively, some therapeutic strategies seek to harness the anti-tumor potential of IL-10 by delivering it in a controlled manner or in combination with other immune-stimulating agents to selectively enhance its beneficial effects while minimizing its immunosuppressive impact.